Effects of restrictive fluid resuscitation on the clinical efficacy of treating traumatic hemorrhagic shock combined with traumatic coagulopathy

This study aims to assess the clinical efficacy of limited fluid resuscitation on traumatic hemorrhagic shock combined with traumatic coagulopathy. A cohort of 120 patients with traumatic hemorrhagic shock complicated with traumatic coagulopathy at admission were divided into two groups based on their emergency fluid resuscitation: the study group (received restrictive fluid resuscitation) and the control group (received conventional fluid resuscitation). Then, the incidence of complications, coagulation parameters, blood gas parameters and electrolyte parameters between the two groups were compared. The incidence of complications in the study group was 6.67%, which was significantly lower than the 20.00% observed in the control group (p < 0.05). Before resuscitation, there was no significant difference in coagulation parameters, blood gas parameters and electrolyte parameters between the two groups (p > 0.05), and in both groups, before and after resuscitation, the coagulation parameters after resuscitation were higher than those before resuscitation, blood gas parameters were lower than those before resuscitation, Mg2+, Cl− and Na+ levels were higher than those before resuscitation, K+ was lower than that before resuscitation, and the difference had statistical significance (p < 0.05). After resuscitation, the coagulation parameters in the study group were significantly lower than those in the control group, the BL (Blood Lactic Acid) and PaCO2 (partial pressure of carbon dioxide in arterial blood) levels in the study group were lower than those in the control group, the BE (base excess) and PaO2 levels were higher than those in the control group, and the differences were statistically significant (p < 0.05). However, after resuscitation, we found no significant difference in electrolyte parameters between both groups (p > 0.05). Restrictive fluid resuscitation was found to significantly enhance coagulation and blood gas function, stabilize water and electrolyte balance and reduce complications in traumatic hemorrhagic shock patients complicated with traumatic coagulopathy. These findings hold substantial clinical significance and merit further exploration.

Restrictive fluid resuscitation; Traumatic hemorrhagic shock; Traumatic coagulation; Clinical efficacy

[1] Kleinveld DJB, Hamada SR, Sandroni C. Trauma-induced coagulopathy. Intensive Care Medicine. 2022; 48: 1642–1645.

[2] Ho VK, Wong J, Martinez A, Winearls J. Trauma-induced coagulopathy: mechanisms and clinical management. Annals of the Academy of Medicine, Singapore. 2022; 51: 40–48.

[3] Duque P, Calvo A, Lockie C, Schöchl H. Pathophysiology of trauma-induced coagulopathy. Transfusion Medicine Reviews. 2021; 35: 80–86.

[4] Jost D, Lemoine S, Lemoine F, Derkenne C, Beaume S, Lanoë V, et al. Prehospital lyophilized plasma transfusion for trauma-induced coagulopathy in patients at risk for hemorrhagic shock: a randomized clinical trial. JAMA Netw Open. 2022; 5: e2223619.

[5] Moore EE, Moore HB, Kornblith LZ, Neal MD, Hoffman M, Mutch NJ, et al. Trauma-induced coagulopathy. Nature Reviews Disease Primers. 2021; 7: 30.

[6] Moore EE, Moore HB, Kornblith LZ, Neal MD, Hoffman M, Mutch NJ, et al. Author correction: trauma-induced coagulopathy. Nature Reviews Disease Primers. 2022; 8: 25.

[7] Jiang S, Wu M, Lu X, Zhong Y, Kang X, Song Y, et al. Is restrictive fluid resuscitation beneficial not only for hemorrhagic shock but also for septic shock?: a meta-analysis. Medicine. 2021; 100: e25143.

[8] Carmichael SP 2nd, Lin N, Evangelista ME, Holcomb JB. The story of blood for shock resuscitation: how the pendulum swings. Journal of the American College of Surgeons. 2021; 233: 644–653.

[9] Paydar S, Taheri Akerdi A, Nikseresht S, Abdolrahimzadeh-Fard H, Shayan L, Ghahramani Z, et al. Should we change our approach to resuscitating victims of femoral fracture? A clinical experience in a busy trauma hospital in Shiraz, Iran. Chinese Journal of Traumatology. 2021; 24: 30–33.

[10] Gratz J, Oberladstätter D, Schöchl H. Trauma-induced coagulopathy and massive bleeding: current hemostatic concepts and treatment strategies. HäMostaseologie. 2021; 41: 307–315.

[11] Jones AR, Miller JL, Jansen JO, Wang HE. Whole blood for resuscitation of traumatic hemorrhagic shock in adults. Advanced Emergency Nursing Journal. 2021; 43: 344–354.

[12] Zhao X, Guo F, Wang C, Wang Z, Chang P, Xue H, et al. Characteristics and risk factors of myocardial injury after traumatic hemorrhagic shock. Journal of Clinical Medicine. 2022; 11: 4799.

[13] Dufour-Gaume F, Frescaline N, Cardona V, Prat NJ. Danger signals in traumatic hemorrhagic shock and new lines for clinical applications. Frontiers in Physiology. 2022; 13: 999011.

[14] Peng HT, Nascimento B, Rhind SG, da Luz L, Beckett A. Evaluation of trauma-induced coagulopathy in the fibrinogen in the initial resuscitation of severe trauma trial. Transfusion. 2021; 61: S49–S57.

[15] Lawson MA, Holle LA, Dow NE, Hennig G, de Laat B, Moore HB, et al. Plasma-based assays distinguish hyperfibrinolysis and shutdown subgroups in trauma-induced coagulopathy. Journal of Trauma and Acute Care Surgery. 2022; 93: 579–587.

[16] Han CY, Wang X, Ringgold KM, Bennett JC, St John AE, Berenson R, et al. Novel melanocortin fusion protein inhibits fibrinogen oxidation and degradation during trauma-induced coagulopathy. Blood. 2023; 142: 724–741.

[17] Stettler GR, Moore EE, Nunns GR, Kelher M, Banerjee A, Silliman CC. Effects of blood components and whole blood in a model of severe trauma-induced coagulopathy. Journal of Surgical Research. 2021; 259: 55–61.

[18] Gosselin AR, White NJ, Bargoud CG, Hanna JS, Tutwiler V. Hyperfibrinolysis drives mechanical instabilities in a simulated model of trauma induced coagulopathy. Thrombosis Research. 2022; 220: 131–140.

[19] Eitel AP, Moore EE, Sauaia A, Kelher MR, Vigneshwar NG, Bartley MG, et al. A proposed clinical coagulation score for research in trauma-induced coagulopathy. Journal of Trauma and Acute Care Surgery. 2023; 94: 798–802.

[20] Sloos PH, Maas MAW, Meijers JCM, Nieuwland R, Roelofs JJTH, Juffermans NP, et al. Anti-high-mobility group box-1 treatment strategies improve trauma-induced coagulopathy in a mouse model of trauma and shock. British Journal of Anaesthesia. 2023; 130: 687–697.